INSIGHTS ON DRUG DEVELOPMENT
-
What Will It Take To Make MCED And MRD A Reality?
Cancer mortality is declining, but the need for earlier action remains. Gain insight into how MCED and MRD are advancing cancer detection and surveillance, helping clinicians identify disease sooner.
-
Sterilization Of APIs – The Alternative: Sterile Filtration Following Aseptic Processing
When terminal sterilization isn't an option for heat- or radiation-sensitive APIs, sterile filtration with aseptic processing protects quality. Get the technical framework.
-
Evaluating Clone Performance And Cell-Specific Productivity
See how continuous process monitoring and automated at-line analytics support confident CHO clone ranking, consistent cultivation, and scale-up by connecting pH, viable cell density, and more.
-
Overcoming Volume And Viscosity Barriers In Biologic Formulations
Learn how advanced containment solutions support high-viscosity biologics, improve device compatibility, enhance injection performance, and address evolving drug delivery and patient care challenges.
-
Patented Process For Olopatadine HCl API Intermediates7/15/2026
See how this patented Wittig-based process for olopatadine HCl achieves Z/E isomer ratios up to 4:1, eliminating dangerous reagents like n-butyl lithium while cutting purification complexity.
-
Unleash The Potential For Polyvinyl Alcohol In Spray Drying6/4/2025
Discover how polyvinyl alcohol (PVA) addresses key formulation challenges in oral solid dosage forms to enhance solubility and stability across diverse APIs, which include emerging drug classes like PROTACs.
-
Scientific Data Is Not AI‑Ready By Default6/26/2026
Convert siloed laboratory data into trusted, AI-ready assets. Learn to enforce data integrity principles at the point of origin to streamline analytics and reduce GxP compliance risks.
-
Accelerating Drug Development: Solid State Chemistry And Strategic Outsourcing5/6/2026
Discover how phase‑appropriate solid‑state chemistry and strategic outsourcing reduce risk, speed development timelines, and enable confident solid‑form selection for complex small‑molecule programs.
-
Best-In-Class Nanodevelopment Capabilities2/3/2025
A highly specialized team excels in creating unique nanoparticles for both small and large molecule APIs. Leveraging cutting-edge technology, they produce nanoformed materials as small as 10 nanometers.
DRUG DEVELOPMENT SOLUTIONS
-
Use a real-time PCR (qPCR) solution for testing cell therapy products that provides sterility results in less than 5 hours.
-
Our highly skilled team of chemists and process engineers, combined with a science-driven project management approach, ensures seamless execution at every stage.
-
Leica DM2000
With their sophisticated modular design and high-performance fluorescence, the Leica DM2000 microscopes are ideal for complex tasks in pathology, cytology, and many other applications. For special diagnostics requirements, the microscope is certified for in-vitro-diagnostics (IVD) like in-vitro-fertilization (IVF).
-
Waters MaxPeak Premier Columns and Solutions dramatically reduce NSA with MaxPeak High Performance Surfaces, innovative technologies designed to reduce analyte loss due to analyte/surface interactions.
-
Gain insight into how a connected approach to experimental design and data management helps reduce errors, accelerate iteration cycles, and unlock deeper insights.